Spots Global Cancer Trial Database for pr1 leukemia peptide vaccine
Every month we try and update this database with for pr1 leukemia peptide vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission | NCT00454168 | Leukemia | PR1 leukemia pe... sargramostim placebo | 18 Years - | National Cancer Institute (NCI) | |
Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome | NCT00513578 | Myelodysplastic... | PR1 leukemia pe... incomplete Freu... sargramostim | 18 Years - | National Cancer Institute (NCI) | |
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome | NCT00004918 | Accelerated Pha... Adult Acute Mye... Chronic Phase C... Previously Trea... Refractory Anem... Refractory Anem... Relapsing Chron... | PR1 leukemia pe... Montanide ISA 5... sargramostim laboratory biom... | 19 Years - | National Cancer Institute (NCI) |